ZalogujUżytkownikHasło
Zaloguj mnie automatycznie przy każdej wizycie    
Rejestracja
Rejestracja
Zaloguj się, by sprawdzić wiadomości
Zaloguj się, by sprawdzić wiadomości
Forum Integrum Consulting - Strona Główna » Pozwolenia zintegrowane

Napisz nowy temat   Odpowiedz do tematu
Relation between histological prostatitis and lower urinary
Zobacz poprzedni temat :: Zobacz następny temat  
Autor Wiadomość
smarty



Dołączył: 10 Paź 2017
Posty: 25

PostWysłany: Wto Paź 10, 2017 06:06    Temat postu: Relation between histological prostatitis and lower urinary Odpowiedz z cytatem

Clinical pharmacokinetics and pharmacodynamic Prostatitis
target attainment of pazufloxacin in prostate tissue: Chronic Prostatitis
Dosing considerations for prostatitis.
The present study examined the clinical pharmacokinetics of pazufloxacin in prostate Chronic Pelvic Pain Syndrome
tissue and estimated the probability of target
attainment for tissue-specific pharmacodynamic BPH Treatment
goals related to treating prostatitis using various intravenous dosing regimens.
Patients with prostatic hypertrophy received prophylactic infusions of pazufloxacin Blood In Semen
(500 mg, n = 23; 1000 mg, n = 25)
for 0.5 h prior to transurethral Blood in Urine
prostate resection. Drug concentrations in plasma (0.5-5 h) and prostate tissue
(0.5-1.5 h) were measured by high-performance Burning While Urinating
liquid chromatography and used for subsequent noncompartmental and three-compartmental analysis.
Monte Carlo simulation was performed to evaluate the probability Difficulty Urinating
of target attainment of a specific minimum inhibitory concentration (MIC) Pain While Urinating
in prostate tissue: the proportion that achieved both area under the drug Frequent Urination
concentration over time curve (AUC)/MIC = 100 and maximum concentration Painful Ejaculation
(Cmax)/MIC = 8. Prostatic penetration Prostatitis Antibiotics
of pazufloxacin was good with mean Cmax ratios (prostate tissue/plasma) Treatment of Prostatitis
of 0.82-0.99 and for AUC, Chronic Prostatitis Symptoms
0.80-0.98. The probability of reaching target MIC Prostatic Hypertrophy
concentrations in prostate tissue was more than 90% for dosing schedules of 0.25 mg/L forNonbacterial Prostatitis
500 mg every 24 h (500 mg daily), 0.5 mg/L for 500 mg every 12 h (1000 mg daily), Causes of Prostatitis
1 mg/L for 1000 mg every 24 h (1000 mg daily), Amoxicillin Prostatitis
and 2 mg/L for 1000 mg every 12 h (2000 mg daily).Treatment for BPH
Importantly, the 2000 mg daily regimen of pazufloxacin produced a profile sufficient to Prostatitis Diet
have an antibacterial effect in prostate tissue against clinical isolates of Escherichia coli Doxycycline Prostatitis
and Klebsiella pneumonia with MIC values less than 2 mg/L Prostatectomy
BPH Symptoms
Prostatitis Cure.

Prostatitis Treatment
Powrót do góry
Ogląda profil użytkownika Wyślij prywatną wiadomość Odwiedź stronę autora
Wyświetl posty z ostatnich:   
Napisz nowy temat   Odpowiedz do tematu    Forum Integrum Consulting - Strona Główna » Pozwolenia zintegrowane Wszystkie czasy w strefie CET (Europa)
Strona 1 z 1

 
Skocz do:  
Nie możesz pisać nowych tematów
Nie możesz odpowiadać w tematach
Nie możesz zmieniać swoich postów
Nie możesz usuwać swoich postów
Nie możesz głosować w ankietach

Powered by phpBB © 2001, 2002 phpBB Group
iCGstation v1.0 Template By Ray © 2003, 2004 iOptional